Thursday, July 28, 2005

ELN Reports in-line

Elan reports in-line (ELN) 7.99 :According to Reuters Estimates ELN reported Q2 (Jun) loss of $0.27 per share, ex items, in-line with the Reuters Estimates consensus of ($0.27); revenues rose 9.4% year/year to $118.6 mln vs the $123.1 mln consensus. Co stated: "While we await the outcome of the ongoing Tysabri safety evaluation, we continue to prudently invest in Tysabri and remain capable and committed to re-introducing it as a therapeutic option for patients should it be appropriate." The company has a CC scheduled for 8:30am.

ELN CC

0 Comments:

Post a Comment

<< Home

Search Engine Submission and Search Engine Optimization

Disclaimer: This website may include stock market analysis. Any ideas or opinions expressed by us is for informational purposes. Trade at your own financial risk as we assume no responsibility for your investing decisions in the markets. Blogarama - The Blogs Directory BlogRankers.com Business Blog Top Sites TopBlog.ws - Top 
Blog, Directory and Search Engine <